在衰老中重新审视氨酸-血管氨酸-氨系统:从长椅到床边和背部的翻译见解
The Journal of clinical investigation
|November 3, 2025
概括
衰老会改变氨酸- ангиотензин-阿尔多素系统 (RAAS),增加有害途径,减少保护性途径. 准RAAS可能会促进健康的衰老并降低疾病风险.
科学领域:
- 心血管生物学 心血管生物学
- 老年学是一门学科.
- 内分泌学 在内分泌学.
背景情况:
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 对于恒温至关重要.
- 老龄化对RAAS产生重大影响,改变了系统和本地活动.
研究的目的:
- 为了回顾RAAS生物学的演变.
- 为了检查衰老对RAAS活动的影响.
- 讨论健康衰老的治疗策略.
主要方法:
- 关于RAAS和衰老的文献综述.
- 在RAAS上分析衰老的分子和功能后果.
- 探索翻译研究和治疗目标.
主要成果:
- 系统性RAAS成分随着年龄的增长而减少.
- 局部RAAS促炎途径 (血管新生素II/AT1R) 的上调.
- 保护性RAAS通路 (血管素II/AT2R,Ang-{1-7) /Mas) 随着年龄的增长而下调.
结论:
- RAAS失调有助于衰老和与年龄相关的疾病.
- 针对RAAS提供了健康衰老干预措施的潜力.
- 翻译性研究是改善患者老龄化结果的关键.
相关概念视频
Hypertension II: Pathophysiology
770
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
770
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229


